| Identification | |
| Name: | 4H-Furo[3,2-c]pyran-2(6H)-one,4-hydroxy- |
| Synonyms: | Patulin(6CI); 4-Hydroxy-4H-furo[3,2-c]pyran-2(6H)-one; Acetic acid,(2,4-dihydroxy-2H-pyran-3(6H)-ylidene)-, 3,4-lactone; Clairformin; Clavacin;Clavatin; Claviformin; DL-Patulin; Expansin; Expansin (antibiotic); Expansine;Mycoin; Mycoin C; Mycoin C3; NSC 32951; NSC 8120; Patuline; Penicidin; Terinin |
| CAS: | 149-29-1 |
| EINECS: | 205-735-2 |
| Molecular Formula: | C7H6 O4 |
| Molecular Weight: | 154.12014 |
| InChI: | InChI=1S/C7H6O4/c8-6-3-4-5(11-6)1-2-10-7(4)9/h1,3,7,9H,2H2 |
| Molecular Structure: | ![(C7H6O4) Patulin(6CI); 4-Hydroxy-4H-furo[3,2-c]pyran-2(6H)-one; Acetic acid,(2,4-dihydroxy-2H-pyran-3(6H)-yli...](https://img1.guidechem.com/chem/e/dict/0/149-29-1.jpg) |
| Properties | |
| Transport: | UN 3462 6.1/PG 2 |
| Density: | 1.52 g/cm3 |
| Refractive index: | 1.603 |
| Water Solubility: | Soluble in water |
| Solubility: | Soluble in water |
| Appearance: | white Crystalline |
| Specification: |
Clavacin ,its CAS NO. is 149-29-1,the synonyms is (2,4-Dihydroxy-2h-pyran-3(6h)-ylidene)aceticacid-3,4-lactone;2,4-dihydroxy-2h-pyran-delta-3(6h),alpha-aceticacid-3,4-lactone ; 2-C(pyran-2(6h)-one,4-hydroxy-4h-furo) ; 2H-pyran-delta(sup3(6h),alpha)-aceticacid,2,4-dihydroxy-,3,4-lactone ; Aceticacid,(2,4-dihydroxy-2h-pyran-3(6h)-ylidene)-,3,4-lactone ; Clairformin ; Patulin . |
| Report: |
IARC Cancer Review: Group 3 IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 7 , 1987,p. 56.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Limited Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 10 , 1976,p. 205.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Inadequate Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 40 , 1986,p. 83.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) . EPA Genetic Toxicology Program. |
| Packinggroup: | I |
| Storage Temperature: | −20°C |
| Color: | Compact prisms or thick plates from ether or chloroform White...crystalline solid CRYSTALS FROM BENZENE Colorless crystals, prisms, or plates from Et2O or trichloromethane |
| Safety Data | |
| Hazard Symbols |
T: Toxic
Xn: Harmful
|
 |
|
